---
title: "SpringWorks Therapeutics Executives Sell Shares"
date: "2025-02-13 09:00:00"
summary: "Reporter NameRelationshipTypeAmountSEC FilingEdris BadreddinChief Operating OfficerSell$1,593,795Form 4Hambleton JulieDirectorSell$730,206Form 4Islam SaqibChief Executive OfficerSell$2,558,236Form 4Edris Badreddin, the Chief Operating Officer of SpringWorks Therapeutics, sold 30,000 shares of common stock on February 10, 2025, at a weighted average price of $53.1265, totaling $1,593,795. Following the sale, Badreddin directly owns 189,712 shares of the..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

| Reporter Name | Relationship | Type | Amount | SEC Filing |
| --- | --- | --- | --- | --- |
| Edris Badreddin | Chief Operating Officer | Sell | $1,593,795 | [Form 4](https://www.sec.gov/Archives/edgar/data/1786966/000110465925012359/xslF345X05/tm256428-1_4seq1.xml) |
| Hambleton Julie | Director | Sell | $730,206 | [Form 4](https://www.sec.gov/Archives/edgar/data/1773427/000110465925012362/xslF345X05/tm256428-2_4seq1.xml) |
| Islam Saqib | Chief Executive Officer | Sell | $2,558,236 | [Form 4](https://www.sec.gov/Archives/edgar/data/1773427/000110465925012363/xslF345X05/tm256428-3_4seq1.xml) |

Edris Badreddin, the Chief Operating Officer of SpringWorks Therapeutics, sold 30,000 shares of common stock on February 10, 2025, at a weighted average price of $53.1265, totaling $1,593,795. Following the sale, Badreddin directly owns 189,712 shares of the company.

Julie Hambleton, a Director at SpringWorks Therapeutics, sold 13,774 shares of Common Stock on February 10, 2025, at a weighted average price of $53.0134, totaling $730,206. After the transaction, Hambleton directly owns 4,095 shares of the company.

Saqib Islam, the Chief Executive Officer and Director of SpringWorks Therapeutics, sold 48,000 shares of Common Stock on February 10, 2025, at a weighted average price of $53.2966, totaling $2,558,236. Following this transaction, Islam directly owns 1,002,502 shares of the company.

[TradingView](https://www.tradingview.com/news/tradingview:5f6a9ace382d5:0-springworks-therapeutics-executives-sell-shares/)
